Amount Raised
$8.09 Million
Round Type
Post-IPO Equity
WalthamBiotechnologyHealth CareTherapeuticsInvestors
Description
On July 14, 2026, Crescent Biopharma, Inc. announced the execution of an underwriting agreement with Jefferies LLC and TD Securities (USA) LLC. This agreement pertains to the public offering of 8,094,793 ordinary shares. The proceeds from this offering are expected to support the company's ongoing development initiatives
Quick answer
Crescent Biopharma raised $8.09 Million in a Post-IPO Equity round, dated July 15, 2026. Investors: TD Securities (USA) LLC and Jefferies LLC. Crescent Biopharma is based in Waltham, Massachusetts, United States.
- How much did Crescent Biopharma raise?
- Crescent Biopharma raised $8.09 Million in a Post-IPO Equity round on July 15, 2026.
- Who invested in Crescent Biopharma?
- TD Securities (USA) LLC and Jefferies LLC are named as investors in this round.
- What does Crescent Biopharma do?
- Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors.
- Where is Crescent Biopharma based and how big is it?
- Crescent Biopharma is based in Waltham, Massachusetts, United States. Fundz records about 41 employees.
- Who are the decision-makers at Crescent Biopharma?
- Fundz holds 2 contacts at Crescent Biopharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Crescent Biopharma that raised within 45 days of this round, from Fundz verified event records.
- AusperBio raised $120M (Series C) on August 28, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
- Revier Therapeutics raised $7M (Seed) on August 25, 2026.
- Airway Therapeutics, LLC raised $50M (Series E) on August 25, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
Who to call at Crescent Biopharma, and when
A new round usually means Crescent Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Crescent Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crescent Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Crescent Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crescent Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Crescent Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.